As PP1β protein expression has been shown to be upregulated in human heart failure and animal models of cardiomyopathy, shRNA-mediated suppression of PP1β appears to be a promising approach to restore impaired SR Ca2+ cycling in the failing heart. The gene discussed is PPP1CB; the disease is cardiomyopathy.